Stay updated on Menin Inhibitor Combo in AML Clinical Trial

Sign up to get notified when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Menin Inhibitor Combo in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page updates to revision v3.0.2, removing the v3.0.1 label and the Back to Top element; core content remains unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T23:06:01.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T19:43:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a new facility name and location, as well as updated drug information for Revumenib and a revised drug combination. Several previous entries related to drug information and genetic resources have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:27:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.9%
    Check dated 2025-08-24T08:14:08.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    1.0%
    Check dated 2025-08-17T04:43:47.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:38:41.000Z thumbnail image

Stay in the know with updates to Menin Inhibitor Combo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Menin Inhibitor Combo in AML Clinical Trial page.